Technology | June 13, 2014

GE Introduces Discovery NM/CT 670 Pro and Q.Metrix

Discovery NM/CT 670 Pro, SPECT/CT

June 13, 2014 — GE Healthcare introduced the Discovery NM/CT 670 Pro at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI 2014). Quantitative accuracy in nuclear medicine is enabled by Q.Metrix and Q.AC, GE Healthcare's newest software innovations in nuclear medicine.

The new Discovery NM/CT 670 Pro integrates the GE Optima CT 540 to maintain its cutting edge CT performance. It combines a 50-slice equivalent CT speed for extended fast coverage of time-critical scans with advanced CT applications, dose management tools such as OptiDose, DoseWatch and ASiR and a streamlined workflow for the most challenging standalone CT procedures.

Quantitative results have been an important part of nuclear medicine imaging for some time as a relative, qualitative assessment. Q.Suite for SPECT/CT represents the next step in GE Healthcare's vision to enable personalized, absolute quantitative SPECT/CT imaging. The two analysis and reporting applications in Q.Suite simplify organ definition and activity calculations to help raise report quality, while improving processing workflow and productivity.

Q.Metrix, a user-friendly application for measuring and reporting standard uptake values in the organ or lesion of interest, enables personalized, quantitative SPECT SUV results with multi-dimensional organ and lesion characterization.

Q.AC is an image reconstruction algorithm for improved accuracy of SPECT attenuation correction that enables quantitative SPECT measurements even at very low dose.

Dosimetry Toolkit, an advanced clinical application that has proven the potential of quantitative SPECT/CT, provides convenient tools for organ segmentation, registration, and activity calculations for Radio-Isotope Therapy planning. With new quantitative tools that generate accurate and more consistent measurements, clinicians can plan treatment therapy quicker and easier than ever before.

For more information: www.genewsroom.com

 

Related Content

Bracco Imaging Acquires Blue Earth Diagnostics
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company...
DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
United Imaging Announces First U.S. Clinical Install of uMI 550 Digital PET/CT System
News | PET-CT | June 19, 2019
United Imaging announced the first U.S. clinical installation of the uMI 550 Digital positron emission tomography/...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
BGN Technologies Introduces Novel Medical Imaging Radioisotope Production Method
News | Radiopharmaceuticals and Tracers | June 05, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel method for...
Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Shine Medical Technologies Breaks Ground on U.S. Medical Isotope Production Facility

Image courtesy of Amen Clinics

News | Radiopharmaceuticals and Tracers | May 10, 2019 | Jeff Zagoudis, Associate Editor
Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S...